Obesity, mammography use and accuracy, and advanced breast cancer risk

Journal of the National Cancer Institute

Volumn 100, Issue 23, 2008, Pages 1724-1733

  Kerlikowske, Karla ^a,f   Walker, Rod ^b   Miglioretti, Diana L ^b,c   Desai, Arati ^d   Ballard Barbash, Rachel ^e   Buist, Diana S M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER GRADING; CANCER RISK; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ETHNIC DIFFERENCE; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; RACE DIFFERENCE;

ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CONFIDENCE INTERVALS; FEMALE; HUMANS; LOGISTIC MODELS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM STAGING; OBESITY; ODDS RATIO; OVERWEIGHT; POSTMENOPAUSE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 57349182181     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn388     Document Type: Article

References (46)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among U.S. adults (1999-2000). JAMA. 2002;288(4):1723-1727.
2. Ogden C, Carroll M, Curtin L, McDowell M, Tabak C, Flegal K. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295(13):1549-1555.
3. van den Brandt P, Spiegelman D, Yaun S, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152(6):514-527.
4. Eliassen A, Colditz G, Rosner B, Willett W, Hankinson S. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006;296(2):193-201.
5. Reinier K, Vacek P, Geller B. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and postmenopausal women. Breast Cancer Res Treat. 2007;103(3):343-348.
6. Ahn J, Schatzkin A, Lacey JJ, et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med. 2007;167(19):2091- 2102.
7. Feigelson H, Jonas C, Teras L, Thun M, Calle E. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 2004;13(2):220-224.
8. Cui Y, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL. Body mass and stage of breast cancer at diagnosis. Int J Cancer. 2002;98(2):279-283.
9. Hall HI, Coates RJ, Uhler RJ, et al. Stage of breast cancer in relation to body mass index and bra cup size. Int J Cancer. 1999;82(1):23-27.
10. Hunt KA, Sickles EA. Effect of obesity on screening mammography: outcomes analysis of 88,346 consecutive examinations. Am J Roetengol. 1999;174(5):1251-1255.
11. Cust A, Stocks T, Lukanova A, et al. The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study. Published online [ahead of print March 11, 2008]. Breast Cancer Res Treat. 2008; doi:10.1007/s10549-008-9958-8.
12. Endogenous Hormones and Breast Cancer Collaborative Group. Body mass index, serum sex hormonesbreast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003;95(16):1218-1226.
13. Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor I and risk of breast cancer. Lancet. 1998;351(9113):1393-1396.
14. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004;363(9418):1346-1353.
15. Gonullu G, Ersoy C, Ersoy A, et al. Relation between insulin resistance and serum concentrations of IL-6 and TNF-alpha in overweight or obese women with early stage breast cancer. Cytokine. 2005;31(4):264-269.
16. Wee CC, McCarthy EP, Davis RB, Phillips RS. Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care. Ann Intern Med. 2000;132(9):697-704.
17. Wee CC, McCarthy EP, Davis RB, Phillips RS. Obesity and breast cancer screening. J Gen Intern Med. 2004;19(4):324-331.
18. Ostbye T, Taylor DH, Yancy WS, Krause KM. Associations between obesity and receipt of screening mammography, papanicolaou tests, and influenza vaccination: results from the health and retirement study (hrs) and the asset and health dynamics among the oldest old (ahead) study. Am J Public Health. 2005;95(9):1623-1630.
19. Cohen S, Signorello L, Gammon M, Blot W. Obesity and recent mammography use among black and white women in the Southern Community Cohort Study (United States). Cancer Causes Control. 2007;18(7):765-773.
20. Zhu K, Wu H, Jatoi I, Potter J, Shriver C. Body mass index and use of mammography screening in the United States. Prev Med. 2006;42(5):381-385.
21. Banks E, Reeves G, Beral V, et al. Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study. BMJ. 2004;329(7464):477.
22. Elmore J, Carney P, Abraham L, et al. The association between obesity and screening mammography accuracy. Arch Intern Med. 2004;164(10):1140-1147.
23. Ballard-Barbash R, Taplin SH, Yankaskas BC, et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. Am J Roetengol. 1997;169(4):1001-1008.
24. Ernster V, Ballard-Barbash R, Barlow W, et al. Detection of DCIS in women undergoing screening mammography. J Natl Cancer Inst. 2002;94(20):1546-1554.
25. Kerlikowske K, Miglioretti D, Ballard-Barbash R, et al. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol. 2003;21(23):4314-4321.
26. Kerlikowske K, Miglioretti D, Buist D, Walker R, Carney P. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2007;99(17):1335-1339.
27. Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Executive summary of the clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults. Arch Intern Med. 1998;158(17):1855-1867.
28. American College of Radiology. The American College of Radiology Breast Imaging Reporting and Data System (BI-RADS). 4th ed. Reston, VA: American College of Radiology; 2003.
29. Yankaskas B, Taplin S, Ichikawa L, et al. Association between mammography timing and measures of screening performance in the U.S. Radiology. 2005;234(2):363-373.
30. Smith-Bindman R, Chu P, Miglioretti D, et al. Comparison of screening mammography in the United States and the United Kingdom. JAMA. 2003;290(16):2129-2137.
31. Smith-Bindman R, Miglioretti D, Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006;144(8):541-553.
32. Miglioretti D, Rutter C, Geller B, et al. Effect of breast augmentation on the accuracy of mammography and cancer characteristics. JAMA. 2004;291(4):442-450.
33. Fleming ID, Cooper JS, Henson DE, et al. AJCC Cancer Staging Manual. 5th ed. New York, NY: Lippincott-Raven; 1997.
34. Boyd N, Martin L, Sun L, et al. Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2086-2092.
35. Lane P, Nelder J. Analysis of covariance and standardization as instances of prediction. Biometrics. 1982;38(3):613-621.
36. Graubard B, Korn E. Predictive margins with survey data. Biometrics. Biometrics. 1999;55(2):652-659.
37. Barlow W, White E, Ballard-Barbash R, et al. A prospective breast cancer risk prediction model among women undergoing screening mammography. J Natl Cancer Inst. 2006;98(17):1204-1214.
38. Cox C. Model-based estimation of the attributable risk in case-control and cohort studies. Stat Methods Med Res. 2006;15(6):611-625.
39. Feigelson H, Patel A, Teras L, Gansler T, Thun M, Calle E. Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women. Cancer. 2006;107(1):12-21.
40. Kerlikowske K. The mammogram that cried Wolfe. N Engl J Med. 2007;356(3):297-300.
41. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. JAMA. 2003;289(24):3243-3253.
42. Bigsby R. Synergistic tumor promoter of estrone and progesterone in methylnitrosourea-induced rat mammary cancer. Cancer Lett. 2002;179(2):113-119.
43. Moore M, Conover J, Franks K. Progestin effects on long-term growth, death, and bcl-xl in breast cancer cells. Biochem Biophys Res Commun. 2000;277(3):650-654.
44. Niedhammer I, Bugel I, Goldberg M, Leclere A. Validity of self-reported weight and height in the French Gazel cohort. Int J Obes. 2000;24(9):1111-1118.
45. Stevens J, Keil JE, Waid R, Gazes PD. Accuracy of current 4-year and 28-year self-reported body weight in an elderly population. Am J Epidemiol. 1990;132(6):1156-1163.
46. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster V. Efficacy of screening mammography: a meta-analysis. JAMA. 1995;273(2):149-154.